Cargando…

Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations

Ischemic heart disease (IHD) is the leading cause of death worldwide. Novel cardioprotective strategies are therefore required to improve clinical outcomes in patients with IHD. Although a large number of novel cardioprotective strategies have been discovered in the research laboratory, their transl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hausenloy, Derek J., Baxter, Gary, Bell, Robert, Bøtker, Hans Erik, Davidson, Sean M., Downey, James, Heusch, Gerd, Kitakaze, Masafumi, Lecour, Sandrine, Mentzer, Robert, Mocanu, Mihaela M., Ovize, Michel, Schulz, Rainer, Shannon, Richard, Walker, Malcolm, Walkinshaw, Gail, Yellon, Derek M.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2010
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965360/ https://www.ncbi.nlm.nih.gov/pubmed/20865418 http://dx.doi.org/10.1007/s00395-010-0121-4

Ejemplares similares

9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotection
por: Bell, R. M., et al.
Publicado: (2016)

The 10th Biennial Hatter Cardiovascular Institute workshop: cellular protection—evaluating new directions in the setting of myocardial infarction, ischaemic stroke, and cardio-oncology
por: Davidson, Sean M., et al.
Publicado: (2018)

Co‐morbidities and co‐medications as confounders of cardioprotection—Does it matter in the clinical setting?
por: Kleinbongard, Petra, et al.
Publicado: (2020)

IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action
por: Lecour, Sandrine, et al.
Publicado: (2021)

ESC Working Group Cellular Biology of the Heart: Position Paper: improving the preclinical assessment of novel cardioprotective therapies
por: Lecour, Sandrine, et al.
Publicado: (2014)

Remote ischaemic conditioning: defining critical criteria for success—report from the 11th Hatter Cardiovascular Workshop
por: Bell, R. M., et al.
Publicado: (2022)

Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning
por: Ferdinandy, Péter, et al.
Publicado: (2023)

Remote ischemic conditioning: from experimental observation to clinical application: report from the 8th Biennial Hatter Cardiovascular Institute Workshop
por: Pickard, Jack M. J., et al.
Publicado: (2014)

Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations
por: Hausenloy, Derek J., et al.
Publicado: (2017)

Health position paper and redox perspectives on reactive oxygen species as signals and targets of cardioprotection
por: Heusch, Gerd, et al.
Publicado: (2023)

Myocardial Infarct Size Reduction Provided by Local and Remote Ischaemic Preconditioning: References Values from the Hatter Cardiovascular Institute
por: Rossello, Xavier, et al.
Publicado: (2018)

The novel adipocytokine visfatin exerts direct cardioprotective effects
por: Lim, Shiang Y, et al.
Publicado: (2008)

Exosomes and cardioprotection – A critical analysis
por: Davidson, Sean M., et al.
Publicado: (2018)

STAT5 fits the RISK profile for cardioprotection
por: Davidson, Sean M., et al.
Publicado: (2012)

Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection
por: Bøtker, Hans Erik, et al.
Publicado: (2018)

The importance of clinically relevant background therapy in cardioprotective studies
por: He, Zhenhe, et al.
Publicado: (2020)

The hatters of eighteenth-century France /
por: Sonenscher, Michael
Publicado: (1987)

Mercurial Poisoning Amongst Hatters
Publicado: (1911)

The Diabetic Heart: Too Sweet for Its Own Good?
por: Whittington, Hannah J., et al.
Publicado: (2012)

The Akt1 isoform is an essential mediator of ischaemic preconditioning
por: Kunuthur, Suma P, et al.
Publicado: (2012)

The RISK pathway leading to mitochondria and cardioprotection: how everything started
por: Yellon, Derek M., et al.
Publicado: (2023)

The GTN patch: a simple and effective new approach to cardioprotection?
por: Yellon, Derek M., et al.
Publicado: (2018)

Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery
por: Hausenloy, Derek J., et al.
Publicado: (2016)

Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner
por: Hausenloy, Derek J, et al.
Publicado: (2013)

The role of PI3Kα isoform in cardioprotection
por: Rossello, Xavier, et al.
Publicado: (2017)

Endothelial cells release cardioprotective exosomes that may contribute to ischaemic preconditioning
por: Davidson, Sean M., et al.
Publicado: (2018)

Co-dependence of the neural and humoral pathways in the mechanism of remote ischemic conditioning
por: Pickard, Jack M. J., et al.
Publicado: (2016)

Role of Macrophages in Cardioprotection
por: Yap, Jonathan, et al.
Publicado: (2019)

Reducing myocardial infarct size: challenges and future opportunities
por: Bulluck, Heerajnarain, et al.
Publicado: (2016)

Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning
por: Hausenloy, Derek J., et al.
Publicado: (2010)

Wake Up and Smell the Coffee: Yet Another No Go for Cardiac Patients?: Editorial to “Caffeinated Coffee Blunts the Myocardial Protective Effects of Statins Against Ischemia–reperfusion Injury in the Rat” by Ye et al.
por: Riksen, Niels P., et al.
Publicado: (2008)

Translational issues for mitoprotective agents as adjunct to reperfusion therapy in patients with ST‐segment elevation myocardial infarction
por: Bøtker, Hans Erik, et al.
Publicado: (2020)

Targeting mitochondrial fusion and fission proteins for cardioprotection
por: Hernandez‐Resendiz, Sauri, et al.
Publicado: (2020)

Parkinson's disease proteins: Novel mitochondrial targets for cardioprotection
por: Mukherjee, Uma A., et al.
Publicado: (2015)

Preconditioning the diabetic human myocardium
por: Sivaraman, Vivek, et al.
Publicado: (2010)

Mitochondria in acute myocardial infarction and cardioprotection
por: Ramachandra, Chrishan J.A., et al.
Publicado: (2020)

Small extracellular vesicles secreted from human amniotic fluid mesenchymal stromal cells possess cardioprotective and promigratory potential
por: Takov, Kaloyan, et al.
Publicado: (2020)

Correction: Loss of PINK1 Increases the Heart's Vulnerability to Ischemia-Reperfusion Injury
por: Siddall, Hilary K., et al.
Publicado: (2013)

Loss of PINK1 Increases the Heart's Vulnerability to Ischemia-Reperfusion Injury
por: Siddall, Hilary K., et al.
Publicado: (2013)

Expanding Mad Hatter's Shakes: Peripheral Nerve Hyperexcitability Syndrome with Artefactual-Looking Lung Lesions
por: Agarwal, Ayush, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_g2is4opc15mfg9llnunffae85q